Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumolysin: a multifunctional pneumococcal virulence factor

J B Rubins1, E N Janoff

  • 1Pulmonary and Infectious Diseases Sections, Veterans Affairs Medical Center, University of Minnesota School of Medicine, Minneapolis 55417, USA.

The Journal of Laboratory and Clinical Medicine
|February 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody blocks acquisition of bacterial colonization through agglutination.

Mucosal immunology·2014
Same author

Limited expression of APRIL and its receptors prior to intestinal IgA plasma cell development during human infancy.

Mucosal immunology·2013
Same author

Pneumococcal IgA1 protease subverts specific protection by human IgA1.

Mucosal immunology·2013
Same author

Inhibition of mesothelioma cell growth in vitro by doxycycline.

The Journal of laboratory and clinical medicine·2001
Same author

Pneumococcal disease in the elderly: what is preventing vaccine efficacy?

Drugs & aging·2001
Same author

Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2001
Same journal

Studies on streptomycin; assay in body fluids.

The Journal of laboratory and clinical medicine·2010
Same journal

Gastrocolic fistula; an experimental study.

The Journal of laboratory and clinical medicine·2010
Same journal

An isolated heart perfusion system adapted to the determination of nongaseous metabolities; with sample data upon the isolated monkey heart.

The Journal of laboratory and clinical medicine·2010
Same journal

A new type of glass cage for metabolism studies.

The Journal of laboratory and clinical medicine·2010
Same journal

A simple electrocardiograph contact electrode for use with the smaller laboratory animal.

The Journal of laboratory and clinical medicine·2010
Same journal

A primary standard for the colorimetric determination of hemoglobin.

The Journal of laboratory and clinical medicine·2010
See all related articles

Pneumolysin (PLY) aids Streptococcus pneumoniae growth by damaging lung barriers and hindering immune responses. Vaccines combining PLY with polysaccharide may offer enhanced protection against pneumococcal infections.

Area of Science:

  • Microbiology and Immunology
  • Pathogenesis of Infectious Diseases
  • Vaccine Development

Background:

  • Streptococcus pneumoniae is a major cause of bacterial pneumonia and sepsis.
  • Pneumolysin (PLY) is a key virulence factor produced by S. pneumoniae.
  • PLY contributes to bacterial growth, dissemination, and immune evasion.

Purpose of the Study:

  • To elucidate the multifaceted roles of pneumolysin (PLY) in Streptococcus pneumoniae pathogenesis.
  • To explore the potential of PLY-polysaccharide conjugates as a basis for novel vaccines.

Main Methods:

  • Analysis of PLY's cytotoxic effects on respiratory epithelium and endothelium.
  • Investigation of PLY's impact on immune cell function and complement activation.
  • Evaluation of PLY's influence on the immunogenicity of pneumococcal polysaccharide (PS).

Related Experiment Videos

Main Results:

  • PLY disrupts pulmonary tissue barriers, facilitating bacterial growth and spread.
  • PLY inhibits bacterial clearance by affecting immune cells and complement.
  • PLY enhances immune responses to pneumococcal polysaccharide (PS).

Conclusions:

  • Pneumolysin is a critical virulence factor that promotes S. pneumoniae infection.
  • PLY-PS conjugates show promise for developing vaccines that induce protective immunity and neutralizing antibodies.
  • Such vaccines could offer dual protection against pneumococcal disease and toxin-induced mucosal injury.